nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—POR—Doxorubicin—muscle cancer	0.711	0.876	CbGbCtD
Nilutamide—CYP2C8—Etoposide—muscle cancer	0.101	0.124	CbGbCtD
Nilutamide—AR—scrotum—muscle cancer	0.0249	0.479	CbGeAlD
Nilutamide—Interstitial pneumonia—Etoposide—muscle cancer	0.00361	0.0264	CcSEcCtD
Nilutamide—POR—cardiac atrium—muscle cancer	0.00277	0.0534	CbGeAlD
Nilutamide—Interstitial lung disease—Etoposide—muscle cancer	0.00247	0.0181	CcSEcCtD
Nilutamide—POR—tendon—muscle cancer	0.00241	0.0465	CbGeAlD
Nilutamide—POR—bone marrow—muscle cancer	0.00234	0.0451	CbGeAlD
Nilutamide—Bone pain—Vincristine—muscle cancer	0.00225	0.0165	CcSEcCtD
Nilutamide—POR—vagina—muscle cancer	0.00224	0.0432	CbGeAlD
Nilutamide—Interstitial pneumonia—Methotrexate—muscle cancer	0.00216	0.0158	CcSEcCtD
Nilutamide—POR—testis—muscle cancer	0.002	0.0385	CbGeAlD
Nilutamide—AR—smooth muscle tissue—muscle cancer	0.0019	0.0366	CbGeAlD
Nilutamide—AR—renal system—muscle cancer	0.00183	0.0352	CbGeAlD
Nilutamide—Phosphatase alkaline increased—Etoposide—muscle cancer	0.00175	0.0128	CcSEcCtD
Nilutamide—AR—cardiac atrium—muscle cancer	0.00164	0.0315	CbGeAlD
Nilutamide—Aspartate aminotransferase increased—Dactinomycin—muscle cancer	0.00158	0.0115	CcSEcCtD
Nilutamide—CYP2C8—renal system—muscle cancer	0.00148	0.0285	CbGeAlD
Nilutamide—Interstitial lung disease—Methotrexate—muscle cancer	0.00148	0.0108	CcSEcCtD
Nilutamide—Lung disorder—Methotrexate—muscle cancer	0.00148	0.0108	CcSEcCtD
Nilutamide—Blood alkaline phosphatase increased—Etoposide—muscle cancer	0.00146	0.0107	CcSEcCtD
Nilutamide—AR—tendon—muscle cancer	0.00143	0.0275	CbGeAlD
Nilutamide—Aspartate aminotransferase increased—Vincristine—muscle cancer	0.00141	0.0103	CcSEcCtD
Nilutamide—Pneumonia—Dactinomycin—muscle cancer	0.00136	0.00993	CcSEcCtD
Nilutamide—AR—vagina—muscle cancer	0.00132	0.0255	CbGeAlD
Nilutamide—Cardiac failure—Etoposide—muscle cancer	0.0013	0.0095	CcSEcCtD
Nilutamide—Lung disorder—Doxorubicin—muscle cancer	0.00128	0.00936	CcSEcCtD
Nilutamide—Erectile dysfunction—Vincristine—muscle cancer	0.00125	0.00912	CcSEcCtD
Nilutamide—CYP2C19—vagina—muscle cancer	0.00123	0.0236	CbGeAlD
Nilutamide—Weight decreased—Vincristine—muscle cancer	0.00122	0.00895	CcSEcCtD
Nilutamide—AR—head—muscle cancer	0.00122	0.0236	CbGeAlD
Nilutamide—Pneumonia—Vincristine—muscle cancer	0.00121	0.00888	CcSEcCtD
Nilutamide—Depression—Vincristine—muscle cancer	0.0012	0.0088	CcSEcCtD
Nilutamide—AR—testis—muscle cancer	0.00118	0.0228	CbGeAlD
Nilutamide—Sweating—Vincristine—muscle cancer	0.00116	0.00846	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Etoposide—muscle cancer	0.00112	0.00818	CcSEcCtD
Nilutamide—Hypoaesthesia—Vincristine—muscle cancer	0.00108	0.00788	CcSEcCtD
Nilutamide—CYP2C8—vagina—muscle cancer	0.00107	0.0206	CbGeAlD
Nilutamide—Alopecia—Dactinomycin—muscle cancer	0.00107	0.00783	CcSEcCtD
Nilutamide—Urinary tract disorder—Vincristine—muscle cancer	0.00107	0.00782	CcSEcCtD
Nilutamide—Urethral disorder—Vincristine—muscle cancer	0.00106	0.00777	CcSEcCtD
Nilutamide—Melaena—Methotrexate—muscle cancer	0.00102	0.00748	CcSEcCtD
Nilutamide—Cough increased—Doxorubicin—muscle cancer	0.000989	0.00724	CcSEcCtD
Nilutamide—Pneumonia—Etoposide—muscle cancer	0.000983	0.00719	CcSEcCtD
Nilutamide—Ill-defined disorder—Dactinomycin—muscle cancer	0.000979	0.00716	CcSEcCtD
Nilutamide—Nocturia—Doxorubicin—muscle cancer	0.000976	0.00714	CcSEcCtD
Nilutamide—Anaemia—Dactinomycin—muscle cancer	0.000975	0.00713	CcSEcCtD
Nilutamide—Alopecia—Vincristine—muscle cancer	0.000957	0.007	CcSEcCtD
Nilutamide—CYP2C8—testis—muscle cancer	0.000955	0.0184	CbGeAlD
Nilutamide—Creatinine increased—Doxorubicin—muscle cancer	0.000952	0.00696	CcSEcCtD
Nilutamide—Malaise—Dactinomycin—muscle cancer	0.000951	0.00696	CcSEcCtD
Nilutamide—Bone pain—Doxorubicin—muscle cancer	0.000946	0.00692	CcSEcCtD
Nilutamide—Leukopenia—Dactinomycin—muscle cancer	0.000944	0.00691	CcSEcCtD
Nilutamide—Gynaecomastia—Methotrexate—muscle cancer	0.000936	0.00685	CcSEcCtD
Nilutamide—Back pain—Vincristine—muscle cancer	0.000912	0.00667	CcSEcCtD
Nilutamide—Phosphatase alkaline increased—Doxorubicin—muscle cancer	0.000906	0.00663	CcSEcCtD
Nilutamide—Discomfort—Dactinomycin—muscle cancer	0.000887	0.00649	CcSEcCtD
Nilutamide—Melaena—Doxorubicin—muscle cancer	0.000885	0.00647	CcSEcCtD
Nilutamide—Hypoaesthesia—Etoposide—muscle cancer	0.000873	0.00638	CcSEcCtD
Nilutamide—Anaemia—Vincristine—muscle cancer	0.000871	0.00637	CcSEcCtD
Nilutamide—Urinary tract disorder—Etoposide—muscle cancer	0.000866	0.00634	CcSEcCtD
Nilutamide—Oedema—Dactinomycin—muscle cancer	0.000861	0.0063	CcSEcCtD
Nilutamide—Urethral disorder—Etoposide—muscle cancer	0.00086	0.00629	CcSEcCtD
Nilutamide—Blood urea increased—Doxorubicin—muscle cancer	0.000855	0.00626	CcSEcCtD
Nilutamide—Leukopenia—Vincristine—muscle cancer	0.000844	0.00617	CcSEcCtD
Nilutamide—Anorexia—Dactinomycin—muscle cancer	0.000821	0.006	CcSEcCtD
Nilutamide—Hypertension—Vincristine—muscle cancer	0.000814	0.00595	CcSEcCtD
Nilutamide—Visual disturbance—Methotrexate—muscle cancer	0.000801	0.00586	CcSEcCtD
Nilutamide—Abnormal vision—Doxorubicin—muscle cancer	0.00079	0.00578	CcSEcCtD
Nilutamide—Alopecia—Etoposide—muscle cancer	0.000775	0.00567	CcSEcCtD
Nilutamide—Oedema—Vincristine—muscle cancer	0.000769	0.00563	CcSEcCtD
Nilutamide—Blood alkaline phosphatase increased—Doxorubicin—muscle cancer	0.000756	0.00553	CcSEcCtD
Nilutamide—Decreased appetite—Dactinomycin—muscle cancer	0.000748	0.00548	CcSEcCtD
Nilutamide—Hyperhidrosis—Vincristine—muscle cancer	0.000744	0.00544	CcSEcCtD
Nilutamide—Back pain—Etoposide—muscle cancer	0.000738	0.0054	CcSEcCtD
Nilutamide—Pain—Dactinomycin—muscle cancer	0.000736	0.00539	CcSEcCtD
Nilutamide—Anorexia—Vincristine—muscle cancer	0.000733	0.00536	CcSEcCtD
Nilutamide—Feeling abnormal—Dactinomycin—muscle cancer	0.000709	0.00519	CcSEcCtD
Nilutamide—Ill-defined disorder—Etoposide—muscle cancer	0.000708	0.00518	CcSEcCtD
Nilutamide—Anaemia—Etoposide—muscle cancer	0.000706	0.00516	CcSEcCtD
Nilutamide—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000704	0.00515	CcSEcCtD
Nilutamide—Hot flush—Doxorubicin—muscle cancer	0.000703	0.00514	CcSEcCtD
Nilutamide—Menopausal symptoms—Doxorubicin—muscle cancer	0.000697	0.0051	CcSEcCtD
Nilutamide—Insomnia—Vincristine—muscle cancer	0.000696	0.00509	CcSEcCtD
Nilutamide—Paraesthesia—Vincristine—muscle cancer	0.000691	0.00505	CcSEcCtD
Nilutamide—Malaise—Etoposide—muscle cancer	0.000688	0.00504	CcSEcCtD
Nilutamide—Leukopenia—Etoposide—muscle cancer	0.000683	0.005	CcSEcCtD
Nilutamide—Abdominal pain—Dactinomycin—muscle cancer	0.000681	0.00498	CcSEcCtD
Nilutamide—Body temperature increased—Dactinomycin—muscle cancer	0.000681	0.00498	CcSEcCtD
Nilutamide—Cardiac failure—Doxorubicin—muscle cancer	0.000674	0.00493	CcSEcCtD
Nilutamide—Loss of consciousness—Etoposide—muscle cancer	0.000671	0.00491	CcSEcCtD
Nilutamide—Decreased appetite—Vincristine—muscle cancer	0.000669	0.00489	CcSEcCtD
Nilutamide—Cough—Etoposide—muscle cancer	0.000666	0.00487	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Vincristine—muscle cancer	0.000664	0.00486	CcSEcCtD
Nilutamide—Hypertension—Etoposide—muscle cancer	0.000659	0.00482	CcSEcCtD
Nilutamide—Constipation—Vincristine—muscle cancer	0.000658	0.00481	CcSEcCtD
Nilutamide—Pain—Vincristine—muscle cancer	0.000658	0.00481	CcSEcCtD
Nilutamide—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.000657	0.00481	CcSEcCtD
Nilutamide—Chest pain—Etoposide—muscle cancer	0.00065	0.00476	CcSEcCtD
Nilutamide—Discomfort—Etoposide—muscle cancer	0.000642	0.0047	CcSEcCtD
Nilutamide—Gastrointestinal pain—Vincristine—muscle cancer	0.000629	0.0046	CcSEcCtD
Nilutamide—Asthenia—Dactinomycin—muscle cancer	0.000618	0.00452	CcSEcCtD
Nilutamide—Blood creatinine increased—Doxorubicin—muscle cancer	0.000616	0.00451	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00061	0.00446	CcSEcCtD
Nilutamide—Body temperature increased—Vincristine—muscle cancer	0.000608	0.00445	CcSEcCtD
Nilutamide—Abdominal pain—Vincristine—muscle cancer	0.000608	0.00445	CcSEcCtD
Nilutamide—Erectile dysfunction—Methotrexate—muscle cancer	0.000604	0.00442	CcSEcCtD
Nilutamide—Dry skin—Doxorubicin—muscle cancer	0.000603	0.00441	CcSEcCtD
Nilutamide—Hyperhidrosis—Etoposide—muscle cancer	0.000602	0.00441	CcSEcCtD
Nilutamide—Anorexia—Etoposide—muscle cancer	0.000594	0.00435	CcSEcCtD
Nilutamide—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000592	0.00433	CcSEcCtD
Nilutamide—Diarrhoea—Dactinomycin—muscle cancer	0.000589	0.00431	CcSEcCtD
Nilutamide—Pneumonia—Methotrexate—muscle cancer	0.000589	0.00431	CcSEcCtD
Nilutamide—Depression—Methotrexate—muscle cancer	0.000583	0.00427	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00058	0.00424	CcSEcCtD
Nilutamide—Influenza—Doxorubicin—muscle cancer	0.000568	0.00416	CcSEcCtD
Nilutamide—Sweating—Methotrexate—muscle cancer	0.000561	0.0041	CcSEcCtD
Nilutamide—Paraesthesia—Etoposide—muscle cancer	0.000559	0.00409	CcSEcCtD
Nilutamide—Haematuria—Methotrexate—muscle cancer	0.000558	0.00408	CcSEcCtD
Nilutamide—Dyspnoea—Etoposide—muscle cancer	0.000555	0.00406	CcSEcCtD
Nilutamide—Angina pectoris—Doxorubicin—muscle cancer	0.000554	0.00405	CcSEcCtD
Nilutamide—Asthenia—Vincristine—muscle cancer	0.000552	0.00404	CcSEcCtD
Nilutamide—Vomiting—Dactinomycin—muscle cancer	0.000547	0.00401	CcSEcCtD
Nilutamide—Rash—Dactinomycin—muscle cancer	0.000543	0.00397	CcSEcCtD
Nilutamide—Decreased appetite—Etoposide—muscle cancer	0.000542	0.00396	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Etoposide—muscle cancer	0.000538	0.00394	CcSEcCtD
Nilutamide—Constipation—Etoposide—muscle cancer	0.000533	0.0039	CcSEcCtD
Nilutamide—Pain—Etoposide—muscle cancer	0.000533	0.0039	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000528	0.00386	CcSEcCtD
Nilutamide—Diarrhoea—Vincristine—muscle cancer	0.000526	0.00385	CcSEcCtD
Nilutamide—Urinary tract disorder—Methotrexate—muscle cancer	0.000519	0.0038	CcSEcCtD
Nilutamide—Urethral disorder—Methotrexate—muscle cancer	0.000515	0.00377	CcSEcCtD
Nilutamide—Weight decreased—Doxorubicin—muscle cancer	0.000514	0.00376	CcSEcCtD
Nilutamide—Feeling abnormal—Etoposide—muscle cancer	0.000513	0.00376	CcSEcCtD
Nilutamide—Hyperglycaemia—Doxorubicin—muscle cancer	0.000513	0.00375	CcSEcCtD
Nilutamide—Nausea—Dactinomycin—muscle cancer	0.000511	0.00374	CcSEcCtD
Nilutamide—Pneumonia—Doxorubicin—muscle cancer	0.00051	0.00373	CcSEcCtD
Nilutamide—Gastrointestinal pain—Etoposide—muscle cancer	0.000509	0.00373	CcSEcCtD
Nilutamide—Dizziness—Vincristine—muscle cancer	0.000509	0.00372	CcSEcCtD
Nilutamide—Visual impairment—Methotrexate—muscle cancer	0.000506	0.0037	CcSEcCtD
Nilutamide—Body temperature increased—Etoposide—muscle cancer	0.000493	0.0036	CcSEcCtD
Nilutamide—Abdominal pain—Etoposide—muscle cancer	0.000493	0.0036	CcSEcCtD
Nilutamide—Urinary tract infection—Doxorubicin—muscle cancer	0.000493	0.0036	CcSEcCtD
Nilutamide—Vomiting—Vincristine—muscle cancer	0.000489	0.00358	CcSEcCtD
Nilutamide—Sweating—Doxorubicin—muscle cancer	0.000486	0.00355	CcSEcCtD
Nilutamide—Rash—Vincristine—muscle cancer	0.000485	0.00355	CcSEcCtD
Nilutamide—Dermatitis—Vincristine—muscle cancer	0.000484	0.00355	CcSEcCtD
Nilutamide—Haematuria—Doxorubicin—muscle cancer	0.000483	0.00354	CcSEcCtD
Nilutamide—Headache—Vincristine—muscle cancer	0.000482	0.00353	CcSEcCtD
Nilutamide—Alopecia—Methotrexate—muscle cancer	0.000464	0.0034	CcSEcCtD
Nilutamide—Nausea—Vincristine—muscle cancer	0.000457	0.00334	CcSEcCtD
Nilutamide—Rhinitis—Doxorubicin—muscle cancer	0.000456	0.00334	CcSEcCtD
Nilutamide—Hypoaesthesia—Doxorubicin—muscle cancer	0.000453	0.00331	CcSEcCtD
Nilutamide—Urinary tract disorder—Doxorubicin—muscle cancer	0.000449	0.00329	CcSEcCtD
Nilutamide—Oedema peripheral—Doxorubicin—muscle cancer	0.000448	0.00328	CcSEcCtD
Nilutamide—Asthenia—Etoposide—muscle cancer	0.000447	0.00327	CcSEcCtD
Nilutamide—Urethral disorder—Doxorubicin—muscle cancer	0.000446	0.00326	CcSEcCtD
Nilutamide—Back pain—Methotrexate—muscle cancer	0.000442	0.00324	CcSEcCtD
Nilutamide—Pruritus—Etoposide—muscle cancer	0.000441	0.00323	CcSEcCtD
Nilutamide—Visual impairment—Doxorubicin—muscle cancer	0.000438	0.00321	CcSEcCtD
Nilutamide—Diarrhoea—Etoposide—muscle cancer	0.000426	0.00312	CcSEcCtD
Nilutamide—Ill-defined disorder—Methotrexate—muscle cancer	0.000424	0.0031	CcSEcCtD
Nilutamide—Anaemia—Methotrexate—muscle cancer	0.000423	0.00309	CcSEcCtD
Nilutamide—Malaise—Methotrexate—muscle cancer	0.000412	0.00302	CcSEcCtD
Nilutamide—Dizziness—Etoposide—muscle cancer	0.000412	0.00301	CcSEcCtD
Nilutamide—Leukopenia—Methotrexate—muscle cancer	0.000409	0.003	CcSEcCtD
Nilutamide—Alopecia—Doxorubicin—muscle cancer	0.000402	0.00294	CcSEcCtD
Nilutamide—Cough—Methotrexate—muscle cancer	0.000399	0.00292	CcSEcCtD
Nilutamide—Vomiting—Etoposide—muscle cancer	0.000396	0.0029	CcSEcCtD
Nilutamide—Rash—Etoposide—muscle cancer	0.000393	0.00287	CcSEcCtD
Nilutamide—Dermatitis—Etoposide—muscle cancer	0.000392	0.00287	CcSEcCtD
Nilutamide—Headache—Etoposide—muscle cancer	0.00039	0.00286	CcSEcCtD
Nilutamide—Chest pain—Methotrexate—muscle cancer	0.000389	0.00285	CcSEcCtD
Nilutamide—Tension—Doxorubicin—muscle cancer	0.000389	0.00284	CcSEcCtD
Nilutamide—Discomfort—Methotrexate—muscle cancer	0.000385	0.00281	CcSEcCtD
Nilutamide—Nervousness—Doxorubicin—muscle cancer	0.000385	0.00281	CcSEcCtD
Nilutamide—Back pain—Doxorubicin—muscle cancer	0.000383	0.0028	CcSEcCtD
Nilutamide—Nausea—Etoposide—muscle cancer	0.00037	0.00271	CcSEcCtD
Nilutamide—Ill-defined disorder—Doxorubicin—muscle cancer	0.000367	0.00269	CcSEcCtD
Nilutamide—Anaemia—Doxorubicin—muscle cancer	0.000366	0.00268	CcSEcCtD
Nilutamide—Hyperhidrosis—Methotrexate—muscle cancer	0.000361	0.00264	CcSEcCtD
Nilutamide—Malaise—Doxorubicin—muscle cancer	0.000357	0.00261	CcSEcCtD
Nilutamide—Anorexia—Methotrexate—muscle cancer	0.000356	0.0026	CcSEcCtD
Nilutamide—Syncope—Doxorubicin—muscle cancer	0.000355	0.0026	CcSEcCtD
Nilutamide—Leukopenia—Doxorubicin—muscle cancer	0.000354	0.00259	CcSEcCtD
Nilutamide—Loss of consciousness—Doxorubicin—muscle cancer	0.000348	0.00255	CcSEcCtD
Nilutamide—Cough—Doxorubicin—muscle cancer	0.000346	0.00253	CcSEcCtD
Nilutamide—Hypertension—Doxorubicin—muscle cancer	0.000342	0.0025	CcSEcCtD
Nilutamide—Insomnia—Methotrexate—muscle cancer	0.000338	0.00247	CcSEcCtD
Nilutamide—Chest pain—Doxorubicin—muscle cancer	0.000337	0.00247	CcSEcCtD
Nilutamide—Paraesthesia—Methotrexate—muscle cancer	0.000335	0.00245	CcSEcCtD
Nilutamide—Discomfort—Doxorubicin—muscle cancer	0.000333	0.00244	CcSEcCtD
Nilutamide—Dyspnoea—Methotrexate—muscle cancer	0.000333	0.00243	CcSEcCtD
Nilutamide—Dry mouth—Doxorubicin—muscle cancer	0.00033	0.00241	CcSEcCtD
Nilutamide—Dyspepsia—Methotrexate—muscle cancer	0.000329	0.0024	CcSEcCtD
Nilutamide—Decreased appetite—Methotrexate—muscle cancer	0.000324	0.00237	CcSEcCtD
Nilutamide—Oedema—Doxorubicin—muscle cancer	0.000323	0.00236	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000322	0.00236	CcSEcCtD
Nilutamide—Pain—Methotrexate—muscle cancer	0.000319	0.00234	CcSEcCtD
Nilutamide—Shock—Doxorubicin—muscle cancer	0.000318	0.00233	CcSEcCtD
Nilutamide—Hyperhidrosis—Doxorubicin—muscle cancer	0.000312	0.00229	CcSEcCtD
Nilutamide—Anorexia—Doxorubicin—muscle cancer	0.000308	0.00225	CcSEcCtD
Nilutamide—Feeling abnormal—Methotrexate—muscle cancer	0.000308	0.00225	CcSEcCtD
Nilutamide—Gastrointestinal pain—Methotrexate—muscle cancer	0.000305	0.00223	CcSEcCtD
Nilutamide—Abdominal pain—Methotrexate—muscle cancer	0.000295	0.00216	CcSEcCtD
Nilutamide—Body temperature increased—Methotrexate—muscle cancer	0.000295	0.00216	CcSEcCtD
Nilutamide—Insomnia—Doxorubicin—muscle cancer	0.000292	0.00214	CcSEcCtD
Nilutamide—Paraesthesia—Doxorubicin—muscle cancer	0.00029	0.00212	CcSEcCtD
Nilutamide—Dyspnoea—Doxorubicin—muscle cancer	0.000288	0.00211	CcSEcCtD
Nilutamide—Dyspepsia—Doxorubicin—muscle cancer	0.000284	0.00208	CcSEcCtD
Nilutamide—Decreased appetite—Doxorubicin—muscle cancer	0.000281	0.00206	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000279	0.00204	CcSEcCtD
Nilutamide—Pain—Doxorubicin—muscle cancer	0.000276	0.00202	CcSEcCtD
Nilutamide—Constipation—Doxorubicin—muscle cancer	0.000276	0.00202	CcSEcCtD
Nilutamide—Asthenia—Methotrexate—muscle cancer	0.000268	0.00196	CcSEcCtD
Nilutamide—Feeling abnormal—Doxorubicin—muscle cancer	0.000266	0.00195	CcSEcCtD
Nilutamide—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000264	0.00193	CcSEcCtD
Nilutamide—Pruritus—Methotrexate—muscle cancer	0.000264	0.00193	CcSEcCtD
Nilutamide—Abdominal pain—Doxorubicin—muscle cancer	0.000255	0.00187	CcSEcCtD
Nilutamide—Body temperature increased—Doxorubicin—muscle cancer	0.000255	0.00187	CcSEcCtD
Nilutamide—Diarrhoea—Methotrexate—muscle cancer	0.000255	0.00187	CcSEcCtD
Nilutamide—Dizziness—Methotrexate—muscle cancer	0.000247	0.00181	CcSEcCtD
Nilutamide—Vomiting—Methotrexate—muscle cancer	0.000237	0.00174	CcSEcCtD
Nilutamide—Rash—Methotrexate—muscle cancer	0.000235	0.00172	CcSEcCtD
Nilutamide—Dermatitis—Methotrexate—muscle cancer	0.000235	0.00172	CcSEcCtD
Nilutamide—Headache—Methotrexate—muscle cancer	0.000234	0.00171	CcSEcCtD
Nilutamide—Asthenia—Doxorubicin—muscle cancer	0.000232	0.0017	CcSEcCtD
Nilutamide—Pruritus—Doxorubicin—muscle cancer	0.000229	0.00167	CcSEcCtD
Nilutamide—Nausea—Methotrexate—muscle cancer	0.000222	0.00162	CcSEcCtD
Nilutamide—Diarrhoea—Doxorubicin—muscle cancer	0.000221	0.00162	CcSEcCtD
Nilutamide—Dizziness—Doxorubicin—muscle cancer	0.000214	0.00156	CcSEcCtD
Nilutamide—Vomiting—Doxorubicin—muscle cancer	0.000205	0.0015	CcSEcCtD
Nilutamide—Rash—Doxorubicin—muscle cancer	0.000204	0.00149	CcSEcCtD
Nilutamide—Dermatitis—Doxorubicin—muscle cancer	0.000204	0.00149	CcSEcCtD
Nilutamide—Headache—Doxorubicin—muscle cancer	0.000202	0.00148	CcSEcCtD
Nilutamide—Nausea—Doxorubicin—muscle cancer	0.000192	0.0014	CcSEcCtD
